A Clinical Trial to Evaluate the Effects of the NeuEve Dryness Treatment Kit on Vaginal Health, Comfort, and Quality of Life in Postmenopausal Women
Public ClinicalTrials.gov record NCT07893795. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a decentralized, single-group, open-label clinical trial evaluating a 12-week regimen of the NeuEve Dryness Treatment Kit (comprising Feminine Moisture Support oral softgels, Bone Support oral capsules, NeuEve Salve vulvar topical cream, NeuEve vaginal suppositories, and NeuEve Multivitamin) in postmenopausal women aged 55-65 who experience vaginal dryness, painful sex, and vaginal itching. The study aims to evaluate the effect of the kit on vaginal symptoms, vaginal pH, vaginal microbiome composition, sexual function, and quality of life over 12 weeks of use.
Study identification
- NCT ID
- NCT07893795
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 40 participants
Conditions and interventions
Conditions
- Relieves Vaginal Dryness / Improves Self-Lubrication
- Improves Strength & Elasticity of Vagina (Aka Collagen and Elastin)
- Improves Vaginal Wall Thickness
- Reduces Pain During Sex
- Reduces Vaginal Odor
- Improves Vaginal Microbiome i.e. Increases Lactobacilli
- Reduces Vaginal Itching, Improves Vaginal Burning & Discharge
- Lowers Vaginal pH to 3.8-4.5
- Improves Libido / Sexual Desire
- Improves Orgasm / Sexual Satisfaction
Eligibility (public fields only)
- Age range
- 55 Years to 65 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2026 (Estimated)
- Primary completion
- Dec 2026 (Estimated)
- Completion
- Dec 2026 (Estimated)
- Last update posted
- Oct 26, 2026
2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Citruslabs | Las Vegas | Nevada | 89118 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07893795, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 26, 2026 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07893795 live on ClinicalTrials.gov.